Pharmacokinetics of cefetamet pivoxil and interaction with cisapride and N- acetylcysteine  Klaus-Jürgen Gutleben, Jörg Eller, Jessica Vöckler, Margot.

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Gut bacterial microbiota and obesity
Approach to diagnosis of infective endocarditis
Interaction of insulin and Burkholderia cepacia
The changing epidemiology of severe infections in the ICU
Herpes zoster in non-hospitalized children
Migrant health—a cause for concern?
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
Hydatid disease Clinical Microbiology and Infection
Successful treatment of Salmonella aortitis with ciprofloxacin
Link between intracellular pathogens and cardiovascular diseases
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
In vitro activity, postantibiotic effect and human monocyte activity of grepafloxacin against Legionella species  Jacques Dubois, Claude St-Pierre  Clinical.
Holt Hanne M. , Søgaard Per , Gahrn-Hansen Bente  
Structure of grepafloxacin relative to activity and safety profile
Vector control: a cornerstone in the malaria elimination campaign
Fourth-generation cephalosporins: a review of in vitro activity, pharmacokinetics, pharmacodynamics and clinical utility  Javier Garau, Walter Wilson,
Changes in fecal flora and comparative multiple-dose pharmacokinetics of ceftibuten, cefpodoxime proxetil and amoxycillin/clavulanate  Jörg Hamacher,
C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins
Sofie Arens, Jan Verhaegen, Ludo Verbist 
Training for the infectious diseases speciality in Norway
F. Grill, P. Muñoz, R. Jofre, E. Bouza 
Interaction of insulin and Burkholderia cepacia
Cephalosporins: a pharmacological update
Retrospective study of CMV retinitis in patients with AIDS
Epidemiology of opportunistic infections in AIDS patients
Laboratory diagnosis and biosafety issues of biological warfare agents
Sepsis and neutropenia induced by clozapine
Uncommon opportunistic fungi: new nosocomial threats
André Bryskier  Clinical Microbiology and Infection 
In vitro selection of antibiotic resistance in Pseudomonas aeruginosa
Metagenomics and probiotics
Effect of antioxidants on the immune response of Helicobacter pylori
Laboratory diagnosis of Clostridium difficile disease
W.A. Craig  Clinical Microbiology and Infection 
Recent developments in staphylococcal scalded skin syndrome
S8 – S47 and O50 – O440 Clinical Microbiology and Infection
Interactions between cytomegalovirus and the p53 tumor suppressor gene in atherosclerotic vascular disease  Inge O. Baas, G. Johan A. Offerhaus, Ralph.
A. Bryskier  Clinical Microbiology and Infection 
Pathogenesis of catheter-related infections: lessons for new designs
Community-acquired pneumonia: epidemiologic and clinical consideration
Abstracts cont. Clinical Microbiology and Infection
Training in infectious diseases and tropical medicine in Britain
Fibronectin concentrations in catheter sepsis
Clinical infection services—the Leiden experience
Outpatient and home parenteral antibiotic therapy (OHPAT) in the UK: a consensus statement by a working party  Dilip Nathwani, Christopher Conlon  Clinical.
Comparative pharmacokinetics of macrolide antibiotics and concentrations achieved in polymorphonuclear leukocytes and saliva  Manuel Fassbender, Hartmut.
Clinical Microbiology and Infection
European guidelines for diagnosis and management of patients with suspected herpes simplex encephalitis  Miles Denton, Kevin G Kerr, Fraser Lewis  Clinical.
Clinical Microbiology and Infection
Empiric therapy of bacterial infections in severe neutropenia
Overview of cefixime use in community-acquired infections
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
Modelling during an emergency: the 2009 H1N1 influenza pandemic
New oral cephalosporins in pediatric community-acquired infections
Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group†   H. Goossens  Clinical.
J.L. Balcázar  Clinical Microbiology and Infection 
Typing of Clostridium difficile
J.A. Pérez-Molina, F. Fernández  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
Outpatient and home parenteral antibiotic therapy (OHPAT) in the UK: a consensus statement by a working party  Dilip Nathwani, Christopher Conlon  Clinical.
Localized Mycobacterium avium complex infection in a patient on HAART
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Vincent Calvez, Marc Grandadam  Clinical Microbiology and Infection 
Presentation transcript:

Pharmacokinetics of cefetamet pivoxil and interaction with cisapride and N- acetylcysteine  Klaus-Jürgen Gutleben, Jörg Eller, Jessica Vöckler, Margot Rau, Peter Koeppe, Jochen Kotwas, Hartmut Lode  Clinical Microbiology and Infection  Volume 3, Issue 2, Pages 170-174 (April 1997) DOI: 10.1111/j.1469-0691.1997.tb00593.x Copyright © 1997 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Serum concentrations of cefetamet (mean ± standard deviation). Clinical Microbiology and Infection 1997 3, 170-174DOI: (10.1111/j.1469-0691.1997.tb00593.x) Copyright © 1997 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 2 Cumulative renal recovery of cefetamet (mean ± standard deviation). Clinical Microbiology and Infection 1997 3, 170-174DOI: (10.1111/j.1469-0691.1997.tb00593.x) Copyright © 1997 European Society of Clinical Infectious Diseases Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.